| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $35.4M | +2.6% |
| Cost of Revenue | $15.4M | -7.4% |
| R&D Expense | $11.8M | -4.4% |
| SG&A Expense | $27.2M | +13.7% |
| Operating Income | -$20.2M | -2.7% |
| Pre-tax Income | -$19.9M | -1.6% |
| Net Income | -$19.9M | -1.6% |
| EPS (Basic) | -$1.96 | +6.2% |
| EPS (Diluted) | -$1.96 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.7M | -53.6% |
| Accounts Receivable | $6.0M | +30.2% |
| Inventory | $11.7M | +80.9% |
| Current Assets | $33.7M | -24.8% |
| Total Assets | $55.8M | -16.0% |
| Current Liabilities | $11.4M | +31.1% |
| Total Liabilities | $13.9M | +19.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.9M | -65.6% |
| Capital Expenditures | $115K | -67.5% |
| Investing Cash Flow | -$115K | +67.5% |
| Financing Cash Flow | -$2.0M | -651.8% |
| Free Cash Flow | -$15.0M | -60.6% |
| +6.2% |
| Stockholders' Equity |
| $42.0M |
| -23.5% |